Psychedelics in Europe With Théo Giubilei

Episode Highlights:Introduction to the Situation in Europe:Overview of Europe's stance on psychedelics and its progress in psychedelic therapies.Historical context: France was the first to prohibit psychotropic substances ahead of the U.S. in the 1960s.Current Research and Stigma Issues:Czech Republic as a pioneer in continued psychedelic research amidst widespread European prohibition.Switzerland's advancements since 2014 in psychedelic therapies for certain conditions.Organizational Efforts and Personal Motivation:Discussion on initiating a European movement to integrate psychedelic therapies.Founder’s background from Strasbourg and motivation for creating the initiative.Challenges in Promoting Psychedelics in the EU:The struggle of integrating a cohesive plan across diverse cultural and political landscapes in Europe.Advocacy through European Citizen Initiative to push legislative changes.Strategic Goals and Legislative Pathway:Campaign to collect 1 million signatures to obligate EU action on psychedelic policies.Goals include establishing common standards for psychedelic care and boosting EU-funded research.Mental Health Crisis and Economic Considerations:Addressing Europe's mental health and economic burdens through psychedelic therapies.The disparity between European initiatives and more advanced legislation in the US and Australia.Public Engagement and Advocacy:Engaging content creators, influencers, and medical professionals in the conversation.Efforts to destigmatize psychedelics by raising public awareness.Impact of Cultural and Political Differences:Addressing the unique cultural and political challenges within different European countries.Adapting strategies to fit local narratives and cultural sensitivities.Looking Ahead:Potential benefits and implementation pathways for psychedelic therapies in Europe.The need for collaboration and knowledge-sharing among EU member states to advance policies and public understanding.Call to Action:Encouragement for listeners to support the European initiative by signing petitions and spreading awareness.Suggestions for engaging in community discussions and using social media platforms to advocate for change.Conclusion:Emphasize the importance of unified efforts to address mental health crises in Europe through innovative therapies.Listeners are encouraged to stay informed and take action to support the movement for psychedelic-assisted therapies.Additional Resources:Follow the New Health Club podcast for further discussions on psychedelic therapies.and check out https://www.psychedelicare.eu/ Hosted on Acast. See acast.com/privacy for more information.